financetom
Business
financetom
/
Business
/
Ashland Completes $10 Million Expansion of Pharmaceutical Production Plant in Brazil
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ashland Completes $10 Million Expansion of Pharmaceutical Production Plant in Brazil
Apr 1, 2025 6:07 AM

08:33 AM EDT, 04/01/2025 (MT Newswires) -- Ashland (ASH) said Tuesday it has completed a $10 million expansion of its pharmaceutical production plant in Cabreuva, Brazil, to meet rising demand for coated tablets in Latin America and Brazil.

As part of the investment, the company has also upgraded its equipment for microbial protection in personal care applications at the research and development laboratory of its technical center in Sao Paulo, Ashland said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Takeda Pharmaceutical Receives FDA 510(k) Clearance for Hyqvia Devices
Takeda Pharmaceutical Receives FDA 510(k) Clearance for Hyqvia Devices
Jul 21, 2025
08:58 AM EDT, 07/21/2025 (MT Newswires) -- Takeda Pharmaceutical ( TAK ) said Monday it has received 510(k) clearance for its HyHub and HyHub Duo devices from the US Food and Drug Administration. The devices reduce the number of steps required to prepare Hyqvia for infusion to patients 17 years and older in a home environment or clinical setting, the...
ProMIS Neurosciences' Alzheimer's Disease Drug Candidate Gets US FDA Fast Track Designation
ProMIS Neurosciences' Alzheimer's Disease Drug Candidate Gets US FDA Fast Track Designation
Jul 21, 2025
08:58 AM EDT, 07/21/2025 (MT Newswires) -- ProMIS Neurosciences ( PMN ) said Monday that the US Food and Drug Administration granted Fast Track designation to its lead candidate PMN310 for treating Alzheimer's disease. The designation supports expedited development for therapies targeting serious conditions with unmet needs, the company said. PMN310 is being evaluated in a phase 1b study for...
Gorilla Technology Group Says Lawsuit Against Culper Research Settled
Gorilla Technology Group Says Lawsuit Against Culper Research Settled
Jul 21, 2025
09:00 AM EDT, 07/21/2025 (MT Newswires) -- Gorilla Technology Group ( GRRR ) said Monday it has settled its lawsuit against Culper Research and its founder, Christian Lamarco, through a confidential agreement that does not involve any financial terms. The litigation followed a short report issued by Culper Research on April 4, while Gorilla filed its complaint on April 16,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved